Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 24, 2026

Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
04:04

Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection

Published on: August 15, 2025

Posterior fossa involvement in a recurrent gliosarcoma.

Srikant Balasubramaniam1, Devendra K Tyagi, Hemant V Sawant

  • 1Department of Neurosurgery, T.N. Medical College and B.Y.L. Nair Hospital, Mumbai, India.

Journal of Neurosciences in Rural Practice
|February 21, 2012
PubMed
Summary

This case study details a rare temporal lobe gliosarcoma (GSM) with posterior fossa recurrence. Aggressive gliosarcomas require further study to understand their biphasic nature and treatment challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Restoring stability at the craniovertebral junction using the Goel technique: Outcomes of posterior C1-C2 fixation in 216 patients.

Journal of craniovertebral junction & spine·2026
Same author

H3K27M-altered diffuse midline glioma: Experience and outcomes from a low-middle income country setting in the contemporary era.

Neuro-oncology advances·2026
Same author

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent.

Cancer immunology, immunotherapy : CII·2026
Same author

Anterior cervical corpectomy and fusion for cervical spine disorders: Institutional insights.

Journal of craniovertebral junction & spine·2026
Same author

Determinants of surgical outcome in spinal tuberculosis: A retrospective analysis of 84 patients.

Journal of craniovertebral junction & spine·2026

Area of Science:

  • Neuro-oncology
  • Surgical Pathology
  • Neurosurgery

Background:

  • Gliosarcoma (GSM) is a rare, aggressive WHO grade 4 tumor, a variant of glioblastoma multiforme.
  • GSMs typically exhibit a predilection for the temporal lobe, but can occur elsewhere in the brain.
Keywords:
Gliosarcomaposterior fossa tumorrecurrence in posterior fossa

More Related Videos

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Related Experiment Videos

Last Updated: May 24, 2026

Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
04:04

Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection

Published on: August 15, 2025

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023